Put companies on watchlist
Petco Health and Wellness
ISIN: US71601V1052
WKN: A2QL60
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Petco Health and Wellness · ISIN: US71601V1052 · PR Newswire (ID: 20240910LA01571)
10 September 2024 10:05PM

Petco Health + Wellness Company, Inc. Reports Second Quarter 2024 Earnings Results


Q2 2024 Overview

  • Net revenue of $1.52 billion decreased 0.5 percent year over year
  • Comparable sales increased 0.3 percent year over year and increased 3.5 percent on a two-year basis
  • GAAP net loss of $24.8 million, or $(0.09) per share, compared to GAAP net loss of $14.6 million, or $(0.05) per share in the prior year
  • Adjusted EBITDA1 of $83.5 million compared to $112.6 million in the prior year
  • Operating Cash Flow of $69.4 million compared to $96.6 million in the prior year
  • Free Cash Flow 1 of $42.0 million compared to $44.6 million in the prior year

SAN DIEGO, Sept. 10, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), a complete partner in pet health and wellness, today announced its second quarter 2024 financial results.

In the second quarter of 2024, Petco delivered net revenue of $1.52 billion, down 0.5 percent versus prior year. On an as-reported basis, the company's consumables business was up 1.5 percent versus prior year, and services and other business was up 3.1 percent versus prior year. Growth in the company's consumables and services and other business was offset by the company's supplies and companion animal business, down 4.7 percent versus prior year. GAAP net loss in the second quarter of 2024 was $24.8 million or $(0.09) per share, compared to GAAP net loss of $14.6 million or $(0.05) per share in the prior year. Adjusted Net Income1 was $(5.9) million or $(0.02) per share, compared to $16.3 million or $0.06 per share in the prior year. Adjusted EBITDA1 was $83.5 million compared to $112.6 million in the prior year.

"Our second quarter results demonstrate the ongoing work of our teams to strengthen our retail fundamentals and accelerate the path to improved profitability," said Joel Anderson, Petco's Chief Executive Officer. "I could not be more excited to lead Petco at this pivotal time. Looking ahead, I see tremendous opportunities for us to significantly improve our operating and financial performance and better leverage Petco's strengths to capture greater share, deliver sustained profitability, and create value for shareholders."

(1)

Adjusted EBITDA, Adjusted Net Income, Adjusted Earnings Per Share ("Adjusted EPS"), and Free Cash Flow are non-GAAP financial measures. See "Non-GAAP Financial Measures" for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures.

Fiscal Q3 2024 Outlook

The company is providing Q3 guidance for revenue, Adjusted EBITDA, and Adjusted EPS, in addition to reaffirming full year interest expense and capital expenditure expectations.

For Fiscal Q3 2024, the company expects: 

Metric*

FQ3 2024

Guidance

Net Revenue

~ $1.5 billion

Adjusted EBITDA

$76 million to $80 million

Adjusted EPS

$(0.03) to $(0.04)

 

For Fiscal 2024 (a 52-week year), the company expects the following, both of which are unchanged:

Metric*

2024

Guidance, YoY

Net interest expense

~$145 million

Capital Expenditures

~$140 million

 

*Assumptions in the guidance include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent. For fiscal 2024, our guidance anticipates a 26 percent tax rate, and 272 million weighted average diluted share count.  Adjusted EBITDA and Adjusted EPS are non-GAAP financial measures and have not been reconciled to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlook for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA and Adjusted EPS are made in a manner consistent with the relevant definitions and assumptions noted herein and in our filings with the Securities and Exchange Commission.

Earnings Conference Call Webcast Information:

Management will host an earnings conference call on September 10, 2024 at 5:00 PM Eastern Time to discuss the company's financial results. The conference call will be accessible through a live webcast. Interested investors and other individuals can access the webcast, earnings release, and earnings presentation via the company's investor relations page at ir.petco.com. A replay of the webcast will be archived on the company's investor relations page through September 24, 2024 until approximately 5:00 PM Eastern Time.

About Petco, The Health + Wellness Co.:

Founded in 1965, Petco is a category-defining health and wellness company focused on improving the lives of pets, pet parents and our own Petco partners. We've consistently set new standards in pet care while delivering comprehensive pet wellness products, services and solutions, and creating communities that deepen the pet-pet parent bond. We operate more than 1,500 pet care centers across the U.S., Mexico and Puerto Rico, which offer merchandise, companion animals, grooming, training and a growing network of on-site veterinary hospitals and mobile veterinary clinics. Our complete pet health and wellness ecosystem is accessible through our pet care centers and digitally at petco.com and on the Petco app. In tandem with Petco Love, a life-changing independent nonprofit organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we've helped find homes for nearly 7 million animals.

Forward-Looking Statements:

This earnings release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact, including, but not limited to, statements regarding our Q3 and full year 2024 guidance, operational reset of our business, our competitive positioning, profitability, cost action plans and associated cost-savings. Such forward-looking statements can generally be identified by the use of forward-looking terms such as "believes," "expects," "may," "intends," "will," "shall," "should," "anticipates," "opportunity," "illustrative," or the negative thereof or other variations thereon or comparable terminology. Although Petco believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these expectations will prove to be correct or that any forward-looking results will occur or be realized. Nothing contained in this earnings release is, or should be relied upon as, a promise or representation or warranty as to any future matter, including any matter in respect of the operations or business or financial condition of Petco. All forward-looking statements are based on current expectations and assumptions about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and contingencies, many of which are outside the control of Petco. Forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results or events to differ materially from the potential results or events discussed in the forward-looking statements, including, without limitation, those identified in this earnings release as well as the following: (i) increased competition (including from multi-channel retailers, mass and grocery retailers, and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments; (vi) macroeconomic pressures in the markets in which we operate, including inflation and prevailing interest rates; (vii) failure to effectively manage our costs; (viii) our reliance on our information technology systems; (ix) our ability to prevent or effectively respond to a data privacy or security breach; (x) our ability to effectively manage or integrate strategic ventures, alliances or acquisitions and realize the anticipated benefits of such transactions; (xi) economic or regulatory developments that might affect our ability to provide attractive promotional financing; (xii) business interruptions and other supply chain issues; (xiii) catastrophic events, political tensions, conflicts and wars (such as the ongoing conflicts in Ukraine and the Middle East), health crises, and pandemics; (xiv) our ability to maintain positive brand perception and recognition; (xv) product safety and quality concerns; (xvi) changes to labor or employment laws or regulations; (xvii) our ability to effectively manage our real estate portfolio; (xviii) constraints in the capital markets or our vendor credit terms; (xix) changes in our credit ratings; (xx) impairments of the carrying value of our goodwill and other intangible assets; (xxi) our ability to successfully implement our operational adjustments, achieve the expected benefits of our cost action plans and drive improved profitability; and (xxii) the other risks, uncertainties and other factors identified under "Risk Factors"  and elsewhere in Petco's Securities and Exchange Commission filings. The occurrence of any such factors could significantly alter the results set forth in these statements.

Petco cautions that the foregoing list of risks, uncertainties and other factors is not complete, and forward-looking statements speak only as of the date they are made. Petco undertakes no duty to update publicly any such forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent legal authority.

 

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited and subject to reclassification)



















13 Weeks Ended





August 3,

2024



July 29,

2023



Percent

Change

Net sales:













Products



$      1,263,749



$    1,278,598



(1 %)

Services and other



260,006



252,136



3 %

Total net sales



1,523,755



1,530,734



(0 %)

Cost of sales:













Products



787,103



789,091



(0 %)

Services and other



155,927



148,639



5 %

Total cost of sales



943,030



937,730



1 %

Gross profit



580,725



593,004



(2 %)

Selling, general and administrative expenses



578,257



568,967



2 %

Operating income (loss)



2,468



24,037



(90 %)

Interest income



(672)



(764)



(12 %)

Interest expense



36,805



37,493



(2 %)

Loss on partial extinguishment of debt





305



(100 %)

Other non-operating (income) loss





(1,795)



(100 %)

Loss before income taxes and income from

   equity method investees



(33,665)



(11,202)



201 %

Income tax (benefit) expense



(4,651)



6,732



N/M

Income from equity method investees



(4,191)



(3,328)



26 %

Net loss attributable to Class A and B-1 common

   stockholders



$            (24,823)



$         (14,606)



70 %















Net loss per Class A and B-1 common share:













Basic



$             (0.09)



$          (0.05)



66 %

Diluted



$             (0.09)



$          (0.05)



66 %















Weighted average shares used in computing net loss per Class A

   and B-1 common share:













Basic



273,074



267,163



2 %

Diluted



273,074



267,163



2 %

 

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)

(Unaudited and subject to reclassification)











 August 3,

2024 



 February 3,

2024 

ASSETS









Current assets:









Cash and cash equivalents



$    127,620



$    125,428

Receivables, less allowance for credit losses1



47,035



44,369

Merchandise inventories, net



672,328



684,502

Prepaid expenses



59,758



58,615

Other current assets



35,152



38,830

Total current assets



941,893



951,744

Fixed assets



2,206,885



2,173,015

Less accumulated depreciation



(1,447,180)



(1,356,648)

Fixed assets, net



759,705



816,367

Operating lease right-of-use assets



1,368,740



1,384,050

Goodwill



980,064



980,297

Trade name



1,025,000



1,025,000

Other long-term assets



201,245



205,694

Total assets



$ 5,276,647



$ 5,363,152

LIABILITIES AND EQUITY









Current liabilities:









Accounts payable and book overdrafts



$    474,496



$    485,131

Accrued salaries and employee benefits



135,235



101,265

Accrued expenses and other liabilities



196,518



200,278

Current portion of operating lease liabilities



306,507



310,507

Current portion of long-term debt and other lease liabilities



5,095



15,962

Total current liabilities



1,117,851



1,113,143

Senior secured credit facilities, net, excluding current portion



1,575,630



1,576,223

Operating lease liabilities, excluding current portion



1,104,709



1,116,615

Deferred taxes, net



219,574



251,629

Other long-term liabilities



127,400



121,113

Total liabilities



4,145,164



4,178,723

Commitments and contingencies









Stockholders' equity:









Class A common stock2



236



231

Class B-1 common stock3



38



38

Class B-2 common stock4





Preferred stock5





Additional paid-in-capital



2,260,381



2,229,582

Accumulated deficit



(1,118,549)



(1,047,243)

Accumulated other comprehensive (loss) income



(10,623)



1,821

Total stockholders' equity



1,131,483



1,184,429

Total liabilities and stockholders' equity



$ 5,276,647



$ 5,363,152





(1)

Allowances for credit losses are $1,859 and $1,806, respectively

(2)

Class A common stock, $0.001 par value: Authorized - 1.0 billion shares; Issued and outstanding - 235.8 million and 231.2 million shares, respectively

(3)

Class B-1 common stock, $0.001 par value: Authorized - 75.0 million shares; Issued and outstanding - 37.8 million shares

(4)

Class B-2 common stock, $0.000001 par value: Authorized - 75.0 million shares; Issued and outstanding - 37.8 million shares

(5)

Preferred stock, $0.001 par value: Authorized - 25.0 million shares; Issued and outstanding - none

 

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited and subject to reclassification)



















26 Weeks Ended







August 3,

2024



July 29,

2023

Cash flows from operating activities:











Net loss





$     (71,306)



$     (16,498)

Adjustments to reconcile net loss to net cash provided by

  operating activities:











Depreciation and amortization





99,305



97,919

Amortization of debt discounts and issuance costs





2,435



2,446

Provision for deferred taxes





(27,782)



(11,002)

Equity-based compensation





29,348



46,248

Impairments, write-offs and losses on sale of fixed and other assets





7,069



1,035

Loss on partial extinguishment of debt







746

Income from equity method investees





(9,077)



(6,458)

Amounts reclassified out of accumulated other comprehensive (loss) income





(2,274)



1,055

Non-cash operating lease costs





207,605



211,576

Other non-operating (income) loss





2,665



(4,614)

Changes in assets and liabilities:











Receivables





(2,083)



(16,679)

Merchandise inventories





11,769



(23,011)

Prepaid expenses and other assets





(7,166)



(14,237)

Accounts payable and book overdrafts





(9,644)



97,062

Accrued salaries and employee benefits





34,591



1,221

Accrued expenses and other liabilities





3,015



(1,238)

Operating lease liabilities





(209,738)



(232,518)

Other long-term liabilities





2,224



1,212

  Net cash provided by operating activities





60,956



134,265

Cash flows from investing activities:











Cash paid for fixed assets





(60,029)



(114,023)

Cash paid for acquisitions, net of cash acquired





(259)



(2,040)

Proceeds from investment





998



10,248

Proceeds from sale of assets





1,019



Cash received from partial surrender of officers' life insurance





206



  Net cash used in investing activities





(58,065)



(105,815)

Cash flows from financing activities:











Borrowings under long-term debt agreements





201,000



Repayments of long-term debt





(201,000)



(60,000)

Debt refinancing costs





(3,028)



Payments for finance lease liabilities





(3,528)



(3,349)

Proceeds from employee stock purchase plan and stock option exercises





1,630



2,454

Tax withholdings on stock-based awards





(3,468)



(4,873)

Proceeds from issuance of common stock





2,500



  Net cash used in financing activities





(5,894)



(65,768)













Net decrease in cash, cash equivalents and restricted cash





(3,003)



(37,318)

Cash, cash equivalents and restricted cash at beginning of period





136,649



213,727

Cash, cash equivalents and restricted cash at end of period





$    133,646



$    176,409

 

NON-GAAP FINANCIAL MEASURES

The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this earnings release to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP). The company has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in this earnings release that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in this earnings release. The non-GAAP financial measures in this earnings release may differ from similarly titled measures used by other companies.

The tables below reflect the calculation of Adjusted EBITDA, Adjusted Net Income, and Adjusted EPS, as applicable, for the thirteen weeks ended August 3, 2024 compared to the thirteen weeks ended July 29, 2023, respectively.

Adjusted EBITDA and Trailing Twelve Month Adjusted EBITDA

Adjusted EBITDA, including Trailing Twelve Month Adjusted EBITDA, is considered a non-GAAP financial measure under the Securities and Exchange Commission's (SEC) rules because it excludes certain amounts included in net income calculated in accordance with GAAP. Management believes that Adjusted EBITDA is a meaningful measure to share with investors because it facilitates comparison of the current period performance with that of the comparable prior period. In addition, Adjusted EBITDA affords investors a view of what management considers to be Petco's core operating performance as well as the ability to make a more informed assessment of such operating performance as compared with that of the prior period. Please see the company's Annual Report on Form 10-K for the fiscal year ended February 3, 2024 filed with the SEC on April 3, 2024 for additional information on Adjusted EBITDA.

(dollars in thousands)



13 Weeks Ended

Reconciliation of Net Loss Attributable to Class A and B-1

   Common Stockholders to Adjusted EBITDA



August 3,

2024



July 29,

2023

Net loss attributable to Class A and B-1 common stockholders



$           (24,823)



$            (14,606)

Add (deduct):









Interest expense, net



36,133



36,729

Income tax (benefit) expense



(4,651)



6,732

Depreciation and amortization



49,718



48,664

Income from equity method investees



(4,191)



(3,328)

Loss on partial extinguishment of debt





305

Goodwill impairment





Asset impairments and write offs



3,561



1,031

Equity-based compensation



11,914



24,119

Other non-operating (income) loss





(1,795)

Mexico joint venture EBITDA (1)



9,902



8,544

Acquisition and divestiture-related costs (2)





Other costs (3)



5,960



6,183

Adjusted EBITDA



$             83,523



$            112,578

Net sales



$     1,523,755



$      1,530,734

Net margin (4)



(1.6 %)



(1.0 %)

Adjusted EBITDA Margin



5.5 %



7.4 %

 

(dollars in thousands)



Trailing Twelve Months

Reconciliation of Net (Loss) Income Attributable to Class A and B-1

   Common Stockholders to Adjusted EBITDA



August 3,

2024



February 3,

2024



July 29,

2023

Net (loss) income attributable to Class A and B-1 common stockholders



$    (1,335,018)



$    (1,280,210)



$           36,154

Add (deduct):













Interest expense, net



147,282



147,504



132,068

Income tax (benefit) expense



(42,465)



(27,613)



24,433

Depreciation and amortization



202,168



200,782



196,177

Income from equity method investees



(18,807)



(16,188)



(14,240)

Loss on partial extinguishment of debt



174



920



746

Goodwill impairment



1,222,524



1,222,524



Asset impairments and write offs



8,867



2,833



1,658

Equity-based compensation



64,959



81,859



81,915

Other non-operating loss (income) 



2,552



(4,727)



(1,892)

Mexico joint venture EBITDA (1)



41,346



38,226



33,583

Acquisition and divestiture-related costs (2)



3,719





2,219

Other costs (3)



39,365



35,193



8,860

Adjusted EBITDA



$         336,666



$         401,103



$         501,681

Net sales



$    6,221,537



$    6,255,284



$    6,165,821

Net margin (4)



(21.5 %)



(20.5 %)



0.6 %

Adjusted EBITDA Margin



5.4 %



6.4 %



8.1 %

 

Adjusted Net Income and Adjusted EPS

Adjusted Net Income and Adjusted diluted Earnings Per Share attributable to Petco common stockholders (Adjusted EPS) are considered non-GAAP financial measures under the SEC's rules because they exclude certain amounts included in the net income attributable to Petco common stockholders and diluted earnings per share attributable to Petco common stockholders calculated in accordance with GAAP. Management believes that Adjusted Net Income and Adjusted EPS are meaningful measures to share with investors because they facilitate comparison of the current period performance with that of the comparable prior period. In addition, Adjusted Net Income and Adjusted EPS afford investors a view of what management considers to be Petco's core earnings performance as well as the ability to make a more informed assessment of such earnings performance with that of the prior period.               

(in thousands, except per share amounts)



13 Weeks Ended

Reconciliation of Diluted EPS to Adjusted EPS



August 3, 2024



July 29, 2023





Amount



Per share



Amount



Per share

Net loss attributable to common stockholders / diluted EPS



$      (24,823)



$           (0.09)



$      (14,606)



$           (0.05)

Add (deduct):

















Income tax (benefit) expense



(4,651)



(0.01)



6,732



0.02

Loss on partial extinguishment of debt







305



0.00

Goodwill impairment









Asset impairments and write offs



3,561



0.01



1,031



0.01

Equity-based compensation



11,914



0.04



24,119



0.09

Other non-operating income







(1,795)



(0.01)

Other costs (3)



5,960



0.02



6,183



0.02

Adjusted pre-tax (loss) income / diluted (loss) earnings per share



$      (8,039)



$        (0.03)



$      21,969



$         0.08

Income tax (benefit) expense at 26% normalized tax rate



(2,090)



(0.01)



5,712



0.02

Adjusted Net (Loss) Income / Adjusted EPS



$         (5,949)



$           (0.02)



$        16,257



$             0.06

 

Free Cash Flow

Free Cash Flow is a non-GAAP financial measure that is calculated as net cash provided by operating activities less cash paid for fixed assets. Management believes that Free Cash Flow, which measures the ability to generate additional cash from business operations, is an important financial measure for use in evaluating the company's financial performance.

The table below reflects the calculation of Free Cash Flow for the thirteen and twenty-six weeks ended August 3, 2024 compared to the thirteen and twenty-six weeks ended July 29, 2023, respectively.

(in thousands)



13 Weeks Ended



26 Weeks Ended





August 3,

2024



July 29,

2023



August 3,

2024



July 29,

2023

Net cash provided by operating activities



$      69,370



$      96,614



$      60,956



$    134,265

Cash paid for fixed assets



(27,388)



(51,973)



(60,029)



(114,023)

Free Cash Flow



$        41,982



$        44,641



$              927



$        20,242

 

Non-GAAP Financial Measures Footnotes

(1)

Mexico Joint Venture EBITDA represents 50 percent of the entity's operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA. In the financial statements, this joint venture is accounted for as an equity method investment and reported net of depreciation and income taxes because such a presentation would not reflect the adjustments made in the calculation of Adjusted EBITDA, we include the 50 percent interest in the company's Mexico joint venture on an Adjusted EBITDA basis to ensure consistency. The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA.











13 Weeks Ended



(in thousands)



August 3,

2024



July 29,

2023



Net income



$       8,822



$       6,656



Depreciation



6,996



6,443



Income tax expense



3,903



2,364



Foreign currency (gain) loss



(380)



395



Interest expense, net



463



1,230



EBITDA



$      19,804



$      17,088



50% of EBITDA



$          9,902



$          8,544





(2)

Acquisition and divestiture-related costs include direct costs resulting from acquiring, integrating, or divesting businesses. These include third-party professional and legal fees, losses on sales of divestitures, and other integration-related costs that would not have otherwise been incurred as part of the company's operations.

(3)

Other costs include, as incurred: restructuring costs and restructuring-related severance costs; legal reserves associated with significant, non-ordinary course legal or regulatory matters; and costs related to certain significant strategic transactions.

(4)

We define net margin as net income attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/petco-health--wellness-company-inc-reports-second-quarter-2024-earnings-results-302244187.html

SOURCE Petco - Investor Relations

Visual performance / price development - Petco Health and Wellness
Smart analysis and research tools can be found here.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2025
PR Newswire
Contact:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942